Table: Ono Pharm -Q1 group results (IFRS)

ONO PHARMACEUTICAL

30/07/2021 04:00

Jul 30 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2021        Jun 30, 2020     Mar 31, 2022 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales               87.36               74.91           345.00    
                   (+16.6 pct)         (+1.3 pct)       (+11.5 pct) 
  Operating           29.79               27.04           103.00    
                   (+10.2 pct)         (+35.3 pct)      (+4.7 pct)  
  Pretax              30.80               28.31           105.00    
                   (+8.8 pct)          (+33.5 pct)      (+4.1 pct)  
  Net                 24.07               21.50            81.50    
                   (+12.0 pct)         (+31.6 pct)      (+8.1 pct)  
  EPS Basic         48.23 yen           43.07 yen       163.28 yen  
  EPS Diluted       48.22 yen           43.06 yen                   
  Ann Div                               50.00 yen        56.00 yen  
  -Q2 Div                               22.50 yen        28.00 yen  
  -Q4 Div                               27.50 yen        28.00 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T